Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adcetris
Marketing
Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
The FDA found Pfizer failed to adequately communicate the indication, contraindications and risks, continuing a wave of actions against drug ads.
Nick Paul Taylor
Apr 14, 2026 4:22am
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
Feb 12, 2025 3:06pm
ASH: Adcetris, Opdivo boost hopes for another ADC, PD-1 combo
Dec 10, 2023 7:30pm
Seagen CEO on his next stop, the Pfizer deal and ADCs
Jun 8, 2023 11:36am
ASCO: Seagen's top-selling drug under threat from Opdivo
Jun 4, 2023 8:00am
Pfizer snaps up ADC cancer specialist Seagen for $43B
Mar 13, 2023 10:51am